AZACITIDINE
- Product NDC
- 64679-096
- 11-digit product format
- 646790096
- Labeler code
- 64679
- Product ID
- 64679-096_ff17cbb9-0fae-40ed-9f4f-04ef8b3e9f31
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- azacitidine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Wockhardt USA LLC.
- Application
- ANDA207518
- Marketing category
- ANDA
- Marketing start
- 2016-09-29
- Marketing end
- 0000-00-00
- Substance
- AZACITIDINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 64679-096-01 | 64679009601 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (64679-096-01) | 2016-09-29 | 0000-00-00 | No | No | Current |